{
  "id": 16290494,
  "title": "HealthStream director Linda Rebrovick sells $420,000 in stock",
  "url": "https://urgent.news/2026/10/24/healthstream-director-linda-rebrovick-sells-420-000-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-24T06:01:06.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/healthstream-director-linda-rebrovick-sells-420000-in-stock-93CH-4970641"
  },
  "original_language": "en",
  "account": "HealthStream Inc. (NASDAQ:HSTM) director Linda Rebrovick recently sold 12,000 shares of the company's common stock, totaling $420,000. The shares were sold at $35.00 per share on October 23, 2026, reducing Rebrovick's direct holdings of HealthStream common stock to 39,329 shares. The sale coincided with HealthStream's stock trading near its 52-week high of $35.23, following a 65% increase over the past six months. With a P/E ratio of 48.37 and a market capitalization of $1.06 billion, InvestingPro analysis suggests the stock is overvalued. Rebrovick had put the sale in motion via a Rule 10b5-1 sales plan, adopted on November 21, 2025. In other news, HealthStream reported Q2 2026 earnings that exceeded analyst expectations, with adjusted earnings per share of $0.23 and revenue of $83.7 million, marking a 12.5% year-over-year increase. Freedom Capital initiated coverage of HealthStream with a Hold rating and a price target of $36.00, valuing the company at three times its fiscal 2027 estimated revenue and 12 times its fiscal 2027 adjusted EBITDA.",
  "summary": null,
  "key_points": [
    "Director Linda Rebrovick sold 12,000 HealthStream shares for $420,000.",
    "Sale occurred on October 23, 2026, at $35.00 per share.",
    "Sale followed 65% stock increase over six months."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}